IQVIA Holdings Inc. Announces CFO Ron Bruehlman to Speak at Bank of America Annual Health Care Conference

On May 7, 2025, IQVIA Holdings Inc. (NYSE:IQV) made a significant announcement regarding its Chief Financial Officer, Ron Bruehlman. He is scheduled to speak at the prestigious Bank of America Annual Health Care Conference on May 13, 2025. The event will take place at 5:20 p.m. ET (2:20 p.m. PT), providing a platform for Bruehlman to share insights on the company’s strategic direction and financial performance in the healthcare sector.

For those interested in the insights that Bruehlman will provide, a live audio webcast of the presentation will be available on the IQVIA Investor Relations website. Additionally, a replay of the webcast will be accessible later the same day, allowing stakeholders and interested parties to catch up on key points discussed during the event.

Founded as a leader in the realm of clinical research services, IQVIA provides comprehensive commercial insights and healthcare intelligence tailored for the life sciences and healthcare industries. The company boasts a robust portfolio of solutions powered by its proprietary IQVIA Connected Intelligence™. This platform equips clients with actionable insights and services that are underpinned by high-quality health data and advanced analytics.

IQVIA has made a strong commitment to the responsible use of artificial intelligence (AI). The company emphasizes the importance of privacy, regulatory compliance, and patient safety in its AI-powered capabilities. Recognizing the high standards required in the industry, IQVIA strives to deliver AI solutions that are trustworthy, scalable, and precise.

With a workforce of approximately 89,000 employees spread across over 100 countries, IQVIA brings together a diverse range of expertise, including healthcare, life sciences, data science, technology, and operational excellence. The organization is dedicated to speeding up the development and commercialization of innovative medical treatments, ultimately aiming to enhance patient outcomes and overall population health.

IQVIA stands out as a global leader in safeguarding individual patient privacy. The company employs a variety of privacy-enhancing technologies and safeguards, which are essential for analyzing vast amounts of health information while ensuring that individual privacy is respected. This dual focus on privacy and data utility allows IQVIA to help healthcare stakeholders identify disease patterns and determine the most effective treatment paths.

IQVIA’s insights and execution capabilities are invaluable for various stakeholders in the healthcare ecosystem, including biotech firms, medical device manufacturers, pharmaceutical companies, medical researchers, government agencies, and payers. By leveraging deep analytical capabilities, the company aids stakeholders in gaining a clearer understanding of diseases, human behaviors, and scientific advances, all aimed at accelerating the journey toward effective cures.

As IQVIA prepares for Ron Bruehlman’s presentation at the Bank of America Annual Health Care Conference, the upcoming event promises to provide significant insights into the company’s strategies and advancements in the healthcare field. With a commitment to responsible AI use and a robust infrastructure for patient privacy, IQVIA continues to establish itself as a leader in driving innovation and improving health outcomes on a global scale.